Navigation Links
XELR8 Holdings Announces Continuation of 'XELR8 To A Million' Promotion
Date:7/2/2008

- Distributors Sales Success Prompts Extension of Promotion -

DENVER, July 2 /PRNewswire-FirstCall/ -- XELR8 Holdings, Inc. (Amex: BZI), a provider of functional foods, beverages and nutritional supplements, announced that "XELR8 To A Million" promotion attained a significant proportion of the $1 million sales goal for the month of June prompting management to offer distributors an opportunity to earn significant bonuses in July.

John Pougnet, CEO, noted, "Our distributors worked exceptionally hard during June and came close to attaining our ambitious goal of $1 million in sales in that month. We felt that such dedication and hard work should be rewarded even if the very aggressive sales goal was not reached. Consequently, we will be offering significant bonuses for sales leadership in July whereby distributors can earn large bonuses depending on their individual sales performance and ranking within the sales organization."

Toward the end of July, XELR8 will post the promotion's progress on its website: http://www.xelr8.com on the page/link marked "XELR8 Performs."

About XELR8 Holdings, Inc.

XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. These include the Company's Eat/Drink/Snack System; Peak Performance System; and its newest market entry, Bazi(TM), a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, one-ounce shot.

XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and Head Coach Mike Shanahan; professional football superstar Cadillac Williams; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit http://www.xelr8.com or http://www.drinkbazi.com

Contacts:

Stephen D. Axelrod, CFA

John Pougnet, CEO Alisa Steinberg (Media)

XELR8 Holdings, Inc. Wolfe Axelrod Weinberger Assoc. LLC

(303) 316-8577 (212) 370-4500

CEO@xelr8.com steve@wolfeaxelrod.com

alisa@wolfeaxelrod.com


'/>"/>
SOURCE XELR8 Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. XELR8 Holdings Announces Record First Quarter Revenue
2. XELR8 Holdings Announces Fiscal 2007 Financial Results
3. XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007
4. Settlement Hearing for In Re PainCare Holdings, Inc. ("PRZ") Securities Litigation
5. American Healthcare Holdings Ranked in Top 100 HCIT Companies
6. Critical Homecare Solutions Holdings, Inc. Reports Full Year 2007 and First Quarter 2008 Results
7. Zimmer Holdings to Partner with AmeriCares for Global Product Donation Program
8. NightHawk Radiology Holdings, Inc. Announces Final Results of Tender Offer; NightHawk Purchases 2,240,883 Shares of Its Common Stock at $8.05 per Share
9. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
10. HMS Holdings Corp. to Present at Jefferies 2nd Annual Healthcare Conference
11. HMS Holdings Corp. to Present at Stephens 2008 Spring Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
(Date:6/20/2017)... ... , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. Kejriwal ... leading-edge care, whether or not they have a referral. Dr. Kejriwal offers state-of-the-art ... laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. This ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... (AHN) Jefferson Hospital is providing physicians with advanced capabilities for diagnosing and treating ... than traditional MRIs, enabling doctors to get a more accurate look inside the ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: